Sage Journals: Discover world-class research

Abstract

Spanish

French

OBJECTIVE:

TO report a case of erythromelalgia in an adolescent patient successfully treated with nitroprusside.

CASE SUMMARY:

A 15-year-old girl with erythromelalgia resistant to aspirin therapy received an infusion of nitroprusside. The response of the erythromelalgia to nitroprusside was dramatic, with complete pain resolution within 17 hours after the start of therapy. No relapse of erythromelalgia was seen when nitroprusside was discontinued and the patient remained well after 6 months.

DISCUSSION:

This case adds to existing literature substantiating the benefit of nitroprusside for the treatment of erythromelalgia in pediatric patients. Erythromelalgia in children may represent a different disease entity than that seen in adults, which is commonly responsive to aspirin therapy. The pathogenesis of erythromelalgia is unclear and precludes formulating a proposed mechanism by which nitroprusside has benefit in children.

CONCLUSIONS:

Nitroprusside is valuable for erythromelalgia resistant to aspirin therapy in pediatric patients. Because of unanswered questions regarding the disease, aspirin remains the agent of first choice in all patients with this rare disease.

Keywords

nitroprusside erythromelalgia

Get full access to this article

View all access options for this article.

References

Kurzrock

Cohen

. Erythromelalgia and myeloproliferative disorders. Arch Intern Med 1989; 149: 105–9.

Babb

Alarcon-Segovia

Fairbairn

. Erythermalgia: Review of 51 cases. Circulation 1964; 29: 136–41.

Kurzrock

Cohen

. Erythromelalgia: Review of clinical characteristics and pathophysiology. Am J Med 1991; 91: 416–22.

Drenth

JPH

Michiels

Ozsoylu

. Acute secondary erythermalgia and hypertension in children. Eur J Pediatr 1995; 154: 882–5.

Michiels

Abels

Steketee

VanVliet

HHDM

Vuzevski

. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocytopenia. Ann Intern Med 1985; 102: 466–71.

Ozsoylu

Caner

Gokalp

. Successful treatment of erythromelalgia with sodium nitroprusside. J Pediatr 1979; 94: 619–21.

Kvernebo

Seem

. Erythromelalgia — Pathophysiological and therapeutic aspects. J Oslo City Hosp 1987; 37: 9–12.

Ozsoylu

Coskun

. Sodium nitroprusside treatment in erythromelalgia. Eur J Pediatr 1984; 141: 185–7.

Rauck

Naveira

Speight

Smith

. Refractory idiopathic erythromelalgia. Anesth Analg 1996; 82: 1097–101.

10.

Friederich

Butterworth

. Sodium nitroprusside: Twenty years and counting. Anesth Analg 1995; 81: 152–62.

11.

Fujuto

Chaudhuri

. Inhibition of constitutive and inducible nitric oxide synthase: Potential selective inhibition. Annu Rev Pharmacol Toxicol 1995; 35: 165–94.

12.

Rindone

Sloane

. Cyanide toxicity from sodium nitroprusside: Risks and management. Ann Pharmacother 1992; 26: 515–9.

Nitroprusside Treatment of Erythromelalgia in an Adolescent Female

Abstract

OBJECTIVE:

CASE SUMMARY:

DISCUSSION:

CONCLUSIONS:

Keywords

Get full access to this article

References